Treatment of HER2-positive (HER2+) hormone-receptor positive (HR plus ) metastatic breast cancer (mBC) with the novel combination of zanidatamab, palbociclib, and fulvestrantSantiago Escriva-De-Romani,Emilio Alba,Alvaro Rodriguez-Lescure,Sara Hurvitz,Juan Miguel Cejalvo,Maria Gion,Cristiano Ferrario,Manuel Ruiz Borrego,Rossanna C. Pezo,Erika Hamilton,Marc Webster, Timothy Pluard,Muralidhar Beeram, Begona Jimenez Rodriguez,Hannah Linden,Cristina Saura, Adam Omidpanah, Phoebe Harvey,Marie-France SavardCANCER RESEARCH（2023）引用 0|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
